01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 1.77
−0.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -3.48x
- Price / sales
- 12.26x
- Price / cash flow
- -6.10x
Enterprise value
- Enterprise value
- HKD 733.1M
- EV / sales
- 11.20x
- EV / EBITDA
- -7.10x
- EV / EBIT
- -6.30x
- Market cap
- HKD 802.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026